These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36203528)

  • 1. A Four-Gene Signature Associated with Radioresistance in Head and Neck Squamous Cell Carcinoma Identified by Text Mining and Data Analysis.
    Zhang Y; Wang H; Wang F; Ma W; Li N; Bo C; Zhao Y; He L; Liu M
    Comput Math Methods Med; 2022; 2022():5693806. PubMed ID: 36203528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
    Ma J; Li R; Wang J
    Mol Med Rep; 2019 Jul; 20(1):622-632. PubMed ID: 31180552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 4. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of methylation and transcriptome identifies a novel risk model for diagnosis, prognosis, and immune characteristics in head and neck squamous cell carcinoma.
    Zhang JW; Gao XL; Li S; Zhuang SH; Liang QW
    Mol Genet Genomics; 2024 Jul; 299(1):71. PubMed ID: 39031208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and clinical significance of tumor markers in head and neck squamous cell carcinoma through bioinformatics analysis.
    Zhao L; Chi W; Cao H; Cui W; Meng W; Guo W; Wang B
    Mol Med Rep; 2019 Jan; 19(1):143-154. PubMed ID: 30431092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
    Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
    Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic discovery of a theranostic signature (SERPINE1/MMP3/COL1A1/SPP1) for head and neck squamous cell carcinomas and identification of antrocinol as a candidate drug.
    Shih ML; Lee JC; Cheng SY; Lawal B; Ho CL; Wu CC; Tzeng DTW; Chen JH; Wu ATH
    Comput Biol Med; 2022 Nov; 150():106185. PubMed ID: 37859283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of SPP1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma.
    Cai X; Zhang H; Li T
    Int J Oral Maxillofac Surg; 2022 Jun; 51(6):732-741. PubMed ID: 34489157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumor stemness and immunity related prognostic factors and sensitive drugs in head and neck squamous cell carcinoma.
    Ye Z; Xiao M; Zhang Y; Zheng A; Zhang D; Chen J; Du F; Zhao Y; Wu X; Li M; Chen Y; Deng S; Shen J; Zhang X; Wen Q; Zhang J; Xiao Z
    Sci Rep; 2024 Jul; 14(1):15962. PubMed ID: 38987626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma.
    Zhu G; Wang W; Yao H; Li H; Zhang C; Meng Y; Wang J; Zhu M; Zheng H
    Sci Rep; 2023 Oct; 13(1):18763. PubMed ID: 37907576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of several senescence-associated genes signature in head and neck squamous cell carcinoma.
    Wang J; Zhou CC; Sun HC; Li Q; Hu JD; Jiang T; Zhou S
    J Clin Lab Anal; 2022 Jul; 36(7):e24555. PubMed ID: 35692082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.